Document is current
Any future updates will be listed below
-
Authors
Al-Naamani, Nadine
Espitia H., Gaudalupe
Velazquez-Moreno, Hugo
Macuil-Chazaro, Benjamin
Serrano-Lopez, Arturo
Vega-Barrientos, Ricardo S.
Hill, Nicholas S.
Preston, Ioana R.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (TL1TR001062)
- License Information
-
More Information
Article History
Received: 20 October 2015
Accepted: 2 January 2016
First Online: 9 January 2016
Compliance with Ethical Standards
:
: Dr Espitia has received an unrestricted grant from Bayer de Mexico S.A. de C.V. Dr Hill has received research grant support from Actelion, Gilead, Bayer, United Therapeutics, and Reata; has served on the medical advisory board for Gilead and Bayer; and has served on the data monitoring committee for Lung LLC (Limited Liability Company). Dr Preston has received grant support from Actelion, Bayer, Gilead, and United Therapeutics; and has served as a consultant for Actelion, Bayer, Gilead, United Therapeutics, and Pfizer. All other authors have reported no conflict of interest.
